SCHEMBL29636833

SCHEMBL29636833

CC(C)(C)OC(=O)N1CCN(c2ccc(-c3cc(Cl)c4ccccc4n3)cc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
LMNA P02545 4/20 0.53
KDM4E B2RXH2 3/20 0.53
GAA P10253 2/20 0.53
GBA1 P04062 2/20 0.51
DHODH Q02127 1/20 0.50
NPSR1 Q6W5P4 2/20 0.49
SMYD3 Q9H7B4 1/20 0.49
HPGD P15428 1/20 0.49
TP53 P04637 1/20 0.49
HDAC3 O15379 1/20 0.48
GPR119 Q8TDV5 1/20 0.48
CCNK O75909 1/20 0.48
CCNA2 P20248 1/20 0.48
CDK2 P24941 1/20 0.48
CCND3 P30281 1/20 0.48
CDK9 P50750 1/20 0.48
CDK6 Q00534 1/20 0.48
JAK2 O60674 1/20 0.48
JAK3 P52333 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23015108 1.00 ALDH1A1 (0.53) ALDH1A1LMNAKDM4EGAAGBA1
SCHEMBL23015375 0.87 MAPT (0.46) ALDH1A1LMNAKDM4EGAADHODH
SCHEMBL29636799 0.87 MAPT (0.46) ALDH1A1LMNAKDM4EGAADHODH
SCHEMBL23015150 0.85 SUV39H2 (0.51) ALDH1A1KDM4ENPSR1HPGDALK
SCHEMBL19989884 0.83 CKS1B (0.55) ALDH1A1KDM4EGBA1HPGDGPR119
SCHEMBL26967706 0.82 MAPT (0.46) ALDH1A1LMNAGBA1NPSR1GPR119
SCHEMBL20768795 0.81 SMYD3 (0.73) ALDH1A1GBA1SMYD3HPGDGPR119
SCHEMBL23015253 0.80 SMYD3 (0.39) GBA1DHODHSMYD3HPGDGPR119
SCHEMBL29636838 0.80 SMYD3 (0.39) GBA1DHODHSMYD3HPGDGPR119
SCHEMBL23015131 0.79 SLC2A1 (0.51) ALDH1A1LMNAKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4017492-A1 MOLECULES THAT BIND TO TDP-43 FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND RELATED DISORDERS Biohaven Therapeutics Ltd. (US) 2022-06-29 EP disclosed